Molnupiravir (or MONEYpiravir): Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk of hospitalization compared with a placebo among adults at a higher risk from the disease

by Paul Alexander

Merck’s Covid-19 pill was no better than placebo in lowering the risk of hospitalization; Molnupiravir can mutate DNA that can cause Cancer, Infertility, Birth Defects